V. Romero, H. Akpinar, and D. Assimos, Kidney stones: a global picture of prevalence, incidence, and associated risk factors, Rev Urol, vol.12, pp.86-96, 2010.

M. Daudon, O. Traxer, E. Lechevallier, and C. Saussine, ??pid??miologie des lithiases urinaires, Progr??s en Urologie, vol.18, issue.12, pp.802-814, 2008.
DOI : 10.1016/j.purol.2008.09.029

E. Worcester, J. Parks, A. Evan, and F. Coe, Renal Function in Patients With Nephrolithiasis, The Journal of Urology, vol.176, issue.2, pp.600-603, 2006.
DOI : 10.1016/j.juro.2006.03.095

D. Strogolo, L. Pras, E. Pontesilli, C. Beccia, E. Ricci-barbini et al., Comparison between SLC3A1 and SLC7A9 Cystinuria Patients and Carriers: A Need for a New Classification, Journal of the American Society of Nephrology, vol.13, issue.10, pp.2547-2553, 2002.
DOI : 10.1097/01.ASN.0000029586.17680.E5

D. Fotiadis, Y. Kanai, and M. Palacin, The SLC3 and SLC7 families of amino acid transporters, Molecular Aspects of Medicine, vol.34, issue.2-3, pp.139-158, 2013.
DOI : 10.1016/j.mam.2012.10.007

C. Bauch and F. Verrey, Apical heterodimeric cystine and cationic amino acid transporter expressed in MDCK cells, American Journal of Physiology - Renal Physiology, vol.283, issue.1, pp.181-189, 2002.
DOI : 10.1152/ajprenal.00212.2001

P. Bartoccioni, M. Rius, A. Zorzano, M. Palacín, and J. Chillarón, Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype, Human Molecular Genetics, vol.17, issue.12, pp.1845-1854, 2008.
DOI : 10.1093/hmg/ddn080

J. Chillaron, M. Font-llitjos, J. Fort, A. Zorzano, and D. Goldfarb, Pathophysiology and treatment of cystinuria, Nature Reviews Nephrology, vol.62, issue.7, pp.424-434, 2010.
DOI : 10.1038/nrneph.2010.69

F. Barbey, D. Joly, P. Rieu, A. Méjean, and M. Daudon, MEDICAL TREATMENT OF CYSTINURIA:, The Journal of Urology, vol.163, pp.1419-1423, 2000.
DOI : 10.1097/00005392-200005000-00005

M. Daudon, F. Cohen-solal, F. Barbey, M. Gagnadoux, and B. Knebelmann, Cystine crystal volume determination: a useful tool in the management of cystinuric patients, Urological Research, vol.31, issue.3, pp.207-211, 2003.
DOI : 10.1007/s00240-003-0319-0

D. Bazin, M. Daudon, C. Combes, and C. Rey, Characterization and Some Physicochemical Aspects of Pathological Microcalcifications, Chemical Reviews, vol.112, issue.10, pp.5092-5120, 2012.
DOI : 10.1021/cr200068d
URL : https://hal.archives-ouvertes.fr/hal-01073611

E. Simpson, C. Linder, E. Sargent, M. Davisson, and L. Mobraaten, Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice, Nature Genetics, vol.25, issue.1, pp.19-27, 1997.
DOI : 10.1038/ng1096-223

P. Coulombe, D. Grégoire, N. Tsanov, and M. Méchali, A spontaneous Cdt1 mutation in 129 mouse strains reveals a regulatory domain restraining replication licensing, Nature Communications, vol.273, p.2065, 2013.
DOI : 10.1038/ncomms3065
URL : https://hal.archives-ouvertes.fr/hal-00852756

L. Ma and A. Fogo, Model of robust induction of glomerulosclerosis in mice: Importance of genetic background, Kidney International, vol.64, issue.1, pp.350-355, 2003.
DOI : 10.1046/j.1523-1755.2003.00058.x

D. Ishola, . Jr, D. Van-der-giezen, B. Hahnel, R. Goldschmeding et al., In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent, Nephrology Dialysis Transplantation, vol.21, issue.3, pp.591-597, 2006.
DOI : 10.1093/ndt/gfi303

T. Yang, Y. Huang, W. Ye, P. Hansen, and J. Schnermann, Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice, AJP: Renal Physiology, vol.288, issue.6, pp.1125-1132, 2005.
DOI : 10.1152/ajprenal.00219.2004

L. Feliubadaló, M. Arbonés, S. Mañ-as, J. Chillarón, and J. Visa, Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis, Human Molecular Genetics, vol.12, issue.17, pp.2097-2108, 2003.
DOI : 10.1093/hmg/ddg228

M. Ercolani, A. Sahota, C. Schuler, M. Yang, and A. Evan, Bladder outlet obstruction in male cystinuria mice, International Urology and Nephrology, vol.75, issue.1, pp.57-63, 2010.
DOI : 10.1007/s11255-009-9597-y

E. Salido, X. Li, Y. Lu, X. Wang, and A. Santana, Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer, Proceedings of the National Academy of Sciences, vol.103, issue.48, pp.18249-54, 2006.
DOI : 10.1073/pnas.0607218103

T. Peters, C. Thaete, S. Wolf, A. Popp, and R. Sedlmeier, A mouse model for cystinuria type I, Human Molecular Genetics, vol.12, issue.17, pp.2109-2120, 2003.
DOI : 10.1093/hmg/ddg189

P. Jungers, D. Joly, F. Barbey, G. Choukroun, and M. Daudon, ESRD caused by nephrolithiasis: Prevalence, mechanisms, and prevention, American Journal of Kidney Diseases, vol.44, issue.5, pp.799-805, 2004.
DOI : 10.1016/S0272-6386(04)01131-X

S. Mulay, O. Kulkarni, K. Rupanagudi, A. Migliorini, and M. Darisipudi, Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1?? secretion, Journal of Clinical Investigation, vol.123, issue.1, pp.236-246, 2013.
DOI : 10.1172/JCI63679DS1

F. Knauf, J. Asplin, I. Granja, I. Schmidt, and G. Moeckel, NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy, Kidney International, vol.84, issue.5, pp.895-901, 2013.
DOI : 10.1038/ki.2013.207